APA (7th ed.) Citation

Zhai, X., Shen, N., Guo, T., Wang, J., Xie, C., Cao, Y., . . . Du, S. (2025). SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression. Oncogene, 44(10), 679. https://doi.org/10.1038/s41388-024-03249-0

Chicago Style (17th ed.) Citation

Zhai, Xingyue, et al. "SPTLC2 Drives an EGFR-FAK-HBEGF Signaling Axis to Promote Ovarian Cancer Progression." Oncogene 44, no. 10 (2025): 679. https://doi.org/10.1038/s41388-024-03249-0.

MLA (9th ed.) Citation

Zhai, Xingyue, et al. "SPTLC2 Drives an EGFR-FAK-HBEGF Signaling Axis to Promote Ovarian Cancer Progression." Oncogene, vol. 44, no. 10, 2025, p. 679, https://doi.org/10.1038/s41388-024-03249-0.